Argent BioPharma : Exclusive Agreement for Malta Manufacturing Facility

About this update from Argent Biopharma Ltd

12 March 2025 Argent BioPharma Ltd. (Argent BioPharma or the Company) Highlights: Argent BioPharma has entered into an agreement with Dr. Shlomo Sadoun, granting him exclusive rights to facilitate a commercial transaction for Argent BioPharma's Malta-based manufacturing facility. [...] This is an abstract of the document. To keep reading, click here and get access to the original version.

View stock analysis, news, and events for Argent Biopharma Ltd